EICHOR
● Active Not Recruiting
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
Condition: Cancer · Sponsor: Bayer
About this study
The aim of this study is to provide darolutamide treatment to patients who participated in a previous study with darolutamide supported by Bayer and the treating doctor considers that the continuation of the treatment with darolutamide to be beneficial. Patients will be carried over from the previous studies and continue in this study with darolutamide treatment on the same dosage. They will also return to the study centers for doctor's visits as often as they did in the previous study.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (335)
| Urology Centers of Alabama, PC - Homewood | Homewood, Alabama, United States | — |
| Ironwood Cancer and Research Centers - Chandler I | Chandler, Arizona, United States | — |
| Tower Urology | Los Angeles, California, United States | — |
| Stanford Cancer Center Palo Alto | Palo Alto, California, United States | — |
| San Diego Clinical Trials | San Diego, California, United States | — |
| TOI Clinical Research | Whittier, California, United States | — |
| Rocky Mountain Regional VA Medical Center - Oncology | Aurora, Colorado, United States | — |
| The Urology Center Of Colorado | Denver, Colorado, United States | — |
| Boca Raton Regional Hospital - Oncology | Boca Raton, Florida, United States | — |
| Jesse Brown VA Medical Center - Cardiology | Chicago, Illinois, United States | — |
| Illinois CancerCare - Peoria | Peoria, Illinois, United States | — |
| Norton Cancer Institute - Downtown | Louisville, Kentucky, United States | — |
+ 323 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04464226